Matthieu Jabaudon1,2, Emmanuel Futier1,2, Laurence Roszyk3,2, Vincent Sapin3,2, Bruno Pereira4, Jean-Michel Constantin1,2. 1. Department of Anesthesiology, Critical Care and Perioperative Medicine, Estaing Hospital, Clermont-Ferrand University Hospital, Clermont-Ferrand, France. 2. EA 7281, R2D2, Clermont University, University of Auvergne, Clermont-Ferrand, France. 3. Department of Medical Biochemistry and Molecular Biology, Estaing University Hospital, Clermont-Ferrand University Hospital, Clermont-Ferrand, France. 4. Department of Clinical Research and Innovation (DRCI), Clermont-Ferrand University Hospital, Clermont-Ferrand, France.
Abstract
BACKGROUND AND OBJECTIVE: The soluble form of the receptor for advanced glycation end-products (sRAGE) is elevated and correlated with severity in patients with acute respiratory distress syndrome (ARDS). The impact of ventilator settings on plasma levels of sRAGE, in patients with or without pre-existing lung injury, remains under-investigated to date. Our objective was to assess the effects of a lung-protective ventilation strategy (combining low tidal volume, positive end-expiratory pressure and recruitment maneuvers), as compared with a non-protective approach (with high tidal volume and zero end-expiratory pressure), on plasma levels of sRAGE in patients without lung injury undergoing major abdominal surgery. METHODS: Plasma samples were obtained from 95 patients enrolled in a large randomized controlled trial of lung-protective ventilation for major abdominal surgery. Plasma levels of sRAGE were measured in duplicate with an enzyme-linked immunoassay on day 1, immediately after surgery, and on postoperative days 1, 3 and 7. RESULTS:Early postoperative plasma levels of sRAGE were significantly lower in the lung-protective ventilation group (n = 47) than in the non-protective ventilation group (n = 48) (mean (standard deviation), 1782 (836) vs 2171 (1678) pg/mL, respectively, P = 0.03). Intraoperative changes in plasma sRAGE were associated with postoperative hypoxemia and ARDS. CONCLUSIONS: A lung-protective ventilation strategy decreased plasma sRAGE in patients without lung injury undergoing major abdominal surgery compared with the patients with non-protective ventilation. This intraoperative decrease could reflect a lesser degree of epithelial injury.
RCT Entities:
BACKGROUND AND OBJECTIVE: The soluble form of the receptor for advanced glycation end-products (sRAGE) is elevated and correlated with severity in patients with acute respiratory distress syndrome (ARDS). The impact of ventilator settings on plasma levels of sRAGE, in patients with or without pre-existing lung injury, remains under-investigated to date. Our objective was to assess the effects of a lung-protective ventilation strategy (combining low tidal volume, positive end-expiratory pressure and recruitment maneuvers), as compared with a non-protective approach (with high tidal volume and zero end-expiratory pressure), on plasma levels of sRAGE in patients without lung injury undergoing major abdominal surgery. METHODS: Plasma samples were obtained from 95 patients enrolled in a large randomized controlled trial of lung-protective ventilation for major abdominal surgery. Plasma levels of sRAGE were measured in duplicate with an enzyme-linked immunoassay on day 1, immediately after surgery, and on postoperative days 1, 3 and 7. RESULTS: Early postoperative plasma levels of sRAGE were significantly lower in the lung-protective ventilation group (n = 47) than in the non-protective ventilation group (n = 48) (mean (standard deviation), 1782 (836) vs 2171 (1678) pg/mL, respectively, P = 0.03). Intraoperative changes in plasma sRAGE were associated with postoperative hypoxemia and ARDS. CONCLUSIONS: A lung-protective ventilation strategy decreased plasma sRAGE in patients without lung injury undergoing major abdominal surgery compared with the patients with non-protective ventilation. This intraoperative decrease could reflect a lesser degree of epithelial injury.
Authors: Heather Lynn; Xiaoguang Sun; Nancy Casanova; Manuel Gonzales-Garay; Christian Bime; Joe G N Garcia Journal: Antioxid Redox Signal Date: 2019-06-18 Impact factor: 8.401
Authors: Ary Serpa Neto; Pedro P Z A Campos; Sabrine N T Hemmes; Lieuwe D Bos; Thomas Bluth; Marion Ferner; Andreas Güldner; Markus W Hollmann; Inmaculada India; Thomas Kiss; Rita Laufenberg-Feldmann; Juraj Sprung; Demet Sulemanji; Carmen Unzueta; Marcos F Vidal Melo; Toby N Weingarten; Anita M Tuip-de Boer; Paolo Pelosi; Marcelo Gama de Abreu; Marcus J Schultz Journal: Eur J Anaesthesiol Date: 2017-04 Impact factor: 4.330
Authors: Erin J Caraher; Sophia Kwon; Syed H Haider; George Crowley; Audrey Lee; Minah Ebrahim; Liqun Zhang; Lung-Chi Chen; Terry Gordon; Mengling Liu; David J Prezant; Ann Marie Schmidt; Anna Nolan Journal: PLoS One Date: 2017-09-19 Impact factor: 3.240